Cellebrite DI Ltd.
CLBT | NASDAQ
$11.56
-$0.06 (-0.52%)
At close: Sep 21, 2026, 4:00 PM ET
$11.58
+$0.02 (+0.17%)
Pre-market:
Sep 22, 2026, 4:56 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 475.68M | 401.2M | 325.11M | 270.65M | 246.25M | 194.91M |
Cost of Revenue | 75.17M | 62.59M | 53.23M | 50.75M | 42.56M | 37.88M |
Gross Profit | 400.5M | 338.61M | 271.88M | 219.91M | 203.69M | 157.03M |
Operating Income | 66.48M | 56.91M | 33.24M | 1.04M | 13.82M | 9.22M |
Interest Income | 24.2M | 18.22M | 8.89M | 2.03M | 847K | 2.82M |
Pretax Income | 90.68M | -275.98M | -75.56M | 120.76M | 82.31M | 11.4M |
Net Income | 78.33M | -283.01M | -81.1M | 120.81M | 71.4M | 5.78M |
Selling & General & Admin | 220.15M | 183.29M | 154.26M | 138.24M | 124.33M | 91.17M |
Research & Development | 113.88M | 98.42M | 84.39M | 80.62M | 65.54M | 54.38M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | 2.27M |
Operating Expenses | 334.02M | 281.7M | 238.64M | 218.86M | 189.87M | 147.82M |
Interest Expense | n/a | 349.76M | n/a | 149K | 153K | 1.42M |
Selling & Marketing Expenses | 154.81M | 132.39M | 110.81M | 97.39M | 76.39M | 61.31M |
Cost & Expenses | 409.2M | 344.3M | 291.87M | 269.61M | 232.42M | 185.7M |
Income Tax Expense | 12.35M | 7.02M | 5.54M | -45K | 10.91M | 5.62M |
Shares Outstanding (Basic) | 252.67M | 209.47M | 190.15M | 182.69M | 144M | 187.17M |
Shares Outstanding (Diluted) | 249.9M | 209.47M | 190.15M | 195.39M | 161.54M | 187.17M |
EPS (Basic) | 0.32 | -1.35 | -0.43 | 0.64 | 0.50 | -0.05 |
EPS (Diluted) | 0.31 | -1.35 | -0.43 | 0.59 | 0.44 | -0.05 |
EBITDA | 103.07M | -265.35M | -65.41M | 130.1M | 89.47M | 17.28M |
EBIT | 91.2M | -275.96M | -75.42M | 120.91M | 82.46M | 11.4M |
Depreciation & Amortization | 11.87M | 10.61M | 10.01M | 9.19M | 7.01M | 5.88M |
Add to Watchlist
Select watchlists to add or remove CLBT